Sartorius Stedim Biotech SA Stock Euronext Paris
Equities
STDM
FR0000053266
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
Apr. 18 | Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix... | |
Apr. 18 | Transcript : Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024 |
Sales 2024 * | 2.99B 3.18B | Sales 2025 * | 3.43B 3.65B | Capitalization | 20.4B 21.72B |
---|---|---|---|---|---|
Net income 2024 * | 350M 373M | Net income 2025 * | 468M 498M | EV / Sales 2024 * | 7.68 x |
Net Debt 2024 * | 2.54B 2.7B | Net Debt 2025 * | 2.24B 2.39B | EV / Sales 2025 * | 6.61 x |
P/E ratio 2024 * |
59
x | P/E ratio 2025 * |
40.8
x | Employees | - |
Yield 2024 * |
0.42% | Yield 2025 * |
0.54% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech SA
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
1st Jan change | Capi. | |
---|---|---|
-4.36% | 183B | |
-3.87% | 105B | |
-4.38% | 67.36B | |
+8.23% | 51.77B | |
+15.54% | 47.29B | |
-1.73% | 40.2B | |
+7.16% | 27.62B | |
-1.68% | 25.51B | |
+9.84% | 24.73B |
- Stock Market
- Equities
- DIM Stock
- STDM Stock